HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Demetris Papamichael Selected Research

Ligands

2/2013Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Demetris Papamichael Research Topics

Disease

11Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 12/2009
7Neoplasms (Cancer)
01/2021 - 06/2008
4Colonic Neoplasms (Colon Cancer)
11/2016 - 02/2014
3Stomach Neoplasms (Stomach Cancer)
03/2022 - 01/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2016
2Neoplasm Metastasis (Metastasis)
02/2013 - 12/2009
2Nasopharyngeal Carcinoma
06/2008 - 04/2005
1Disease Progression
01/2021
1Obesity
01/2021
1Frailty
11/2018
1Rectal Neoplasms (Rectal Cancer)
04/2016
1Adenocarcinoma
01/2016
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
01/2014
1Exanthema (Rash)
10/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
06/2008
1Epstein-Barr Virus Infections
06/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2008
1Infectious Mononucleosis (Glandular Fever)
06/2008

Drug/Important Bio-Agent (IBA)

6Cetuximab (Erbitux)FDA Link
06/2015 - 12/2009
3Biomarkers (Surrogate Marker)IBA
03/2017 - 02/2013
2Irinotecan (Camptosar)FDA LinkGeneric
01/2018 - 05/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018 - 12/2015
2Leucovorin (Folinic Acid)FDA Link
01/2018 - 12/2015
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 12/2015
2IMM-101IBA
10/2016 - 01/2016
2GemcitabineFDA Link
10/2016 - 01/2016
2DNA (Deoxyribonucleic Acid)IBA
02/2014 - 06/2008
2Messenger RNA (mRNA)IBA
12/2013 - 02/2013
2Monoclonal AntibodiesIBA
12/2013 - 02/2013
2ErbB Receptors (EGF Receptor)IBA
08/2010 - 12/2009
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Biological ProductsIBA
01/2020
1ElementsIBA
11/2018
1velourIBA
01/2018
1afliberceptIBA
01/2018
1Chromogranin AIBA
03/2017
1Sodium Glutamate (Accent)IBA
11/2016
1Dihydrotachysterol (AT 10)IBA
12/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014
1Bevacizumab (Avastin)FDA Link
02/2014
1Tumor Biomarkers (Tumor Markers)IBA
02/2014
1Neutralizing AntibodiesIBA
02/2014
1Epithelial Cell Adhesion MoleculeIBA
01/2014
1EpiregulinIBA
12/2013
1human ERBB2 proteinIBA
12/2013
1Carrier Proteins (Binding Protein)IBA
12/2013
1Formaldehyde (Formol)FDA Link
12/2013
1Insulin (Novolin)FDA Link
12/2013
1ParaffinIBA
12/2013
1Growth Factor ReceptorsIBA
12/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013
1Ephrin-A2 (Ephrin A2)IBA
12/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2013
1AmphiregulinIBA
12/2013
1Codon (Codons)IBA
02/2013
1LigandsIBA
02/2013
1Gefitinib (Iressa)FDA Link
10/2011
1Tyrosine Kinase InhibitorsIBA
10/2011
1Docetaxel (Taxotere)FDA Link
05/2011
1PlatinumIBA
05/2011
1AntibodiesIBA
08/2010
1Panitumumab (Vectibix)FDA Link
08/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2008
1HLA-DRB1 Chains (HLA DRB1)IBA
06/2008
1Paclitaxel (Taxol)FDA LinkGeneric
04/2005
1Cisplatin (Platino)FDA LinkGeneric
04/2005
1Epirubicin (Ellence)FDA LinkGeneric
04/2005

Therapy/Procedure

9Therapeutics
01/2021 - 12/2009
8Drug Therapy (Chemotherapy)
03/2022 - 07/2010
4Adjuvant Chemotherapy
01/2020 - 12/2015
2Induction Chemotherapy
01/2021 - 04/2005
2Radiotherapy
04/2016 - 04/2005
1Metastasectomy
02/2014
1Ligation
02/2014